Myostatin blockade with a form of the ActRIIB receptor has potent anti‐obesity and insulin sensitizing actions
Year: 2009
Type: article
Source: The FASEB Journal
Authors: Imo Akpan, Ravindra Dhir, Xiaoyan Yin, Jennifer Lachey, Marcus Goncalves, Rexford S Ahima
Institutions: University of Pennsylvania, Acceleron Pharma (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2299658714
